Risk Assessment in the Life Sciences
In this webcast presented by RAPS, quality expert Blake Jensen (Founder, Principal Consultant, B3 Quality Consulting) discusses risk assessment and risk management approaches that support growth more efficiently, as well as the upstream and downstream impacts of risk assessment.
Featured Resources
The future of life sciences validation and compliance is not so far away. Already, we are seeing life sciences companies rush to integrate AI where possible, while at the same time striving to manage risk with fewer human and material resources available.
Read the WhitepaperLearn how Nuvolo is leveraging a combination of Sware's Res_Q Platform and expert resources to deliver a fully GxP compliant offering to the life sciences industry, enabling Nuvolo and their customers to meet business goals.
Read the case studyManual computer software validation processes cost life sciences organizations up to 30% in additional project budget. As companies struggle to keep up with a surge of app and software integrations, they incur validation debt: the mounting cost of stretched resources, blanket testing, and missed GxP requirements.
Download the EbookValidation to Sware by
Res_Q was built to serve the unique, complex requirements around CSV for GxP systems. Leverage our intelligent validation automation platform and our deep compliance expertise to your benefit — reach out today to schedule a no-pressure session — We’re here to help you.